Olodaterol Hydrochloride/Tiotropium Bromide Hydrate

盐酸奥达特罗/噻托溴铵

Report date: 2026/03/23 20:03:44

Base Information

Drug NameOlodaterol Hydrochloride/Tiotropium Bromide Hydrate
Drug Alias NameOlodaterol Hydrochloride/Tiotropium Bromide盐酸奥达特罗/噻托溴铵水合物Tiotropium Bromide Hydrate and Olodaterol Hydrochloride噻托溴铵盐酸奥达特罗盐酸奥达特罗噻托溴铵 +[14] 
ClassificationSmall molecules
Mechanisms of ActionBeta-2 adrenergic receptor agonistsMuscarinic acetylcholine receptor M3 antagonists
TargetsBeta-2 adrenergic receptorMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsPulmonary Disease, Chronic Obstructive
Approved Indications in ChinaPulmonary Disease, Chronic Obstructive
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[41] 
CombinationsYes Tiotropium BromideOlodaterol Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBoehringer Ingelheim International Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. KgBoehringer Ingelheim International Gmbh
Inactive CompaniesBoehringer Ingelheim Pharma Gmbh & Co KgBoehringer Ingelheim International Trading (Shanghai) Co Ltd
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeR03A
Related LinksKEGG